Development of a quantitative antigen-specific cell-based ELISA for the 7G7/B6 monoclonal antibody directed toward IL-2Rα

Journal of Immunological Methods

Volumn 277, Issue 1-2, 2003, Pages 87-100

  Yang, Xiao Yi ^a   Jiang, Hengguang ^a   Hartmann, Wanda K ^a   Mitra, Gautam ^a   Soman, Gopalan ^a  

^a SAIC FREDERICK INC   (United States)

Author keywords

7G7 B6; Antibody; Assay validation; CbELISA; IL 2R

Indexed keywords

INTERLEUKIN 2 RECEPTOR; MONOCLONAL ANTIBODY;

ANTIGEN BINDING; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; CELL LINE; CELL SPECIFICITY; CELL SURFACE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DATA ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; T CELL LEUKEMIA; VALIDATION PROCESS;

EID: 0038208159     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-1759(03)00178-9     Document Type: Article

References (51)

1. Alvord W.G., Rossio J.L. Determining confidence limits for drug potency in immunoassay. J. Immunol. Methods. 157:1993;155.
2. Bani L., Pasquier V., Kryworuchko M., Salamero J., Theze J. Unstimulated human CD4 lymphocytes express a cytoplasmic immature form of the common cytokine receptor gamma-chain. J. Immunol. 167:2001;344.
3. Brown P.S. Jr., Parenteau G.L., Dirbas F.M., Garsia R.J., Goldman C.K., Bukowwski M.A., Junghans R.P., Queen C., Hakimi J., Benjamin W.R., Clark R.E., Waldman T.A. Anti-Tac-H, a humanized antibody to the interlukin 2 receptor, prolongs primate cardiac allograft survival. Proc. Natl. Acad. Sci. U. S. A. 88:1991;2663.
4. Courtney L.P., Phelps J.L., Karavodin L.M. An anti-IL-2 antibody increases serum half-life and improves anti-tumor efficacy of human recombinant interleukin-2. Immunopharmacology. 28:1994;223.
5. Fayer B.E., Soni P.P., Binger M.H., Mould D.R., Sato H. Determination of humanized anti-Tac in human serum by sandwich enzyme linked immunosorbent assay. J. Immunol. Methods. 186:1995;47.
6. Finney D.J. Radioligand assay. Biometrics. 32:1976;721.
7. Goldstein A.M., Marcon L., Cullen B.R., Nelson D.L. A competitive enzyme-linked immunoassay (ELISA) for the measurement of soluble human interleukin-2 receptors (IL-2R, Tac protein). J. Immunol. Methods. 107:1988;103.
8. Grunow R., D'Apuzzo M., Wyss-Coray T., Frutig K., Pichler W.J. A cell surface ELISA for the screening of monoclonal antibodies to antigens on viable cells in suspension. J. Immunol. Methods. 171:1994;93.
9. Hakimi J., Seals C., Anderson L.E., Podlaski F.J., Lin P., Danho W., Jenson J.C., Perkins A., Donadio P.E., Familletti P.C., Pan Y.E., Tsien W., Chizzonite R.A., Casabo L., Nelson D.L., Cullen B.R. Biochemical and functional analysis of soluble human interleukin-2 receptor produced in rodent cells. Solid-phase reconstitution of a receptor-ligand binding reaction. J. Biol. Chem. 262:1987;17336.
10. Hakimi J., Chizzonite R., Luke D.R., Familletti C., Bailon P., Kondas J., Pilson R.S., Lin P., Weber D.V., Spence C., Mondini L.J., Gallatti V.H., Korn L., Waldmann T.A., Queen C., Benjamin W.R. Reduced immunogenicity and improved pharmacokinetics of humanized anti-Tac in cynomolgus mokeys. J. Immunol. 147:1991;1352.
11. Hakimi J., Ha V.C., Lin P., Campbell E., Gately M.K., Tsudo M., Payne P.W., Waldmann T.A., Grant A.J., Tsien W.H., Schneider W.P. Humanized Mik beta 1, a humanized antibody to the IL-2 receptor beta-chain that acts synergistically with humanized anti-TAC. J. Immunol. 151:1993;1075.
12. Healy M.J.R. Statical analysis of radioimmunoassay data. Biochem. J. 130:1972;207.
13. Hori T., Uchiyama T., Tsudo M., Umadome H., Ohno H., Fukuhara S., Kita K., Uchino H. Establishment of an interleukin 2-dependent human T cell line from a patient with T cell chronic lymphocytic leukemia who is not infected with human T cell leukemia/lymphoma virus. Blood. 70:1987;1069.
14. Janszen M., Buck D., Maino V.C. Functional and molecular properties of CD25 monoclonal antibodies. Knapp W., Dorken B., Gilks W.R., Rieber E.P., Schmidt R.E., Stein H., von dem Borne A.E.G.K. Leucocyte Typing IV: White Cell Differentiation Antigens. 1989;404 Oxford Univ. Press, New York.
15. Junghans R.P., Waldmann T.A., Landolfi N.F., Avdalovic N.M., Schneider W.P., Queen C. Anti-Tac-H, a humanized antibody to the interleukin 2 receptor with new features for immunotherapy in malignant and immune disorders. Cancer Res. 50:1990;1495.
16. Junghans R.P., Stone A.L., Lewis M.S. Biophysical characterization of a recombinant soluble interleukin-2 receptor (Tac). J. Biol. Chem. 271:1996;10453.
17. Kirkman R.L., Barrett L.V., Gaulton G.N., Kelley V.E., Ythier A., Strom T.B. Administration of an anti-interleukin 2 receptor monoclonal antibody prolongs cardiac allograft survival in mice. J. Exp. Med. 162:1985;358.
18. Morris R.E. Cellular enzyme-linked immunospecific assay (CELISA): III. Use of the CELISA to quantitate monoclonal antibodies bound to HLA antigens and to subset-specific antigens on cell surfaces. Transplantation. 36:1983;719.
19. Morris J.C., Waldmann T.A. Advances in IL-2 receptor targeted treatment. Ann. Rheum. Dis. 59(Suppl. 1):2000;i109.
20. Morris R.E., Thomas P.T., Hong R. Cellular enzyme-linked immunospecific assay (CELISA): I. A new micromethod that detects antibodies to cell-surface antigens. Hum. Immunol. 5:1982;1.
21. Nelson D.L., Kurman C.C. Targeting human IL-2 receptors for diagnosis and therapy. Proc. Soc. Exp. Biol. Med. 206:1994;309.
22. Nix B., Wild D. Calibration curve-fitting. Wild D. The Immunoassay Handbook. 2001;198 Nature Publishing Group, London.
23. Osawa H., Josimovic-Alasevic O., Diamantstein T. Enzyme-linked immunosorbent assay of mouse interleukin-2 receptors. J. Immunol. Methods. 92:1986;109.
24. Otani H., Siegel J.P., Erdos M., Gnarra J.R., Toledano M.B., Sharon M., Mostowski H., Feinberg M.B., Pierce J.H., Leonard W.J. Interleukin (IL)-2 and IL-3 induce distinct but overlapping responses in murine IL-3-dependent 32D cells transduced with human IL-2 receptor beta chain: involvement of tyrosine kinase(s) other than p56lck. Proc. Natl. Acad. Sci. U. S. A. 89:1992;2789.
25. Ouzaki A., Osawa H., Diamantstein T. An ELISA that detects cell-associated and released rat IL-2 receptors in a soluble form. J. Immunol. Methods. 100:1987;243.
26. Pastan I., Lovelace E.T., Gallo M.G., Rutherford A.V., Magnani J.L., Willingham M.C. Characterization of monoclonal antibodies B1 and B3 that react with mucinous adenocarcinomas. Cancer Res. 51:1991;3781.
27. Phillips K.E., Herring B., Wilson L.A., Rickford M.S., Zhang M., Goldman C.K., Tso J.Y., Waldmann T.A. IL-2Rα-directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Rα interaction. Cancer Res. 60:2000;6977.
28. Posner M.R., Antoniou D., Griffin J., Schlossman S.F., Lazarus H. An enzyme-linked immunosorbent assay (ELISA) for the detection of monoclonal antibodies to cell surface antigens on viable cells. J. Immunol. Methods. 48:1982;23.
29. Queen C., Schneider W.P., Selick H.E., Payne P.W., Landolfi N.F., Duncan J.F., Avdalovic N.M., Levitt M., Junghans R.P., Waldmann T.A. A humanized antibody that binds to the interleukin 2 receptor. Proc. Natl. Acad. Sci. U. S. A. 86:1989;10029.
30. Queen C., Schneider W.P., Waldmann T.A. Humanized antibodies to the IL-2 receptor. Clark M. Protein Engineering of Antibody Molecules for Prophylactic and Therapeutic Applications in Man. 1993;159 Academic Titles, Nottingham.
31. Robb R.J., Kutny R.M. Structure-function relationships for the IL2-receptor system. IV. Analysis of the sequence and ligand-binding properties of soluble Tac protein. J Immunol. 139:1987;855.
32. Rodbard D., Hutt D.M. Statistical analysis of radioimmunoassays and radioimmunometric assays: a generalized weighted, iterative, least square method for logistic curve fitting. Proceedings, Symposium on Radioimmunoassay and Related Procedures in Medicium. vol. 1:1974;165 International Atomic Energy Agency, Vienna.
33. Rubin L.A., Kurman C.C., Biddison W.E., Goldman N.D., Nelson D.L. A monoclonal antibody, 7G7/B6, binds to an epitope on the human interleukin-2 (IL-2) receptor that is distinct from that recognized by IL-2 or anti-Tac. Hybridoma. 4:1985;91.
34. Schlosser M., Witt S., Ziegler B., Ziegler M. Influence of target cell preparation on binding of monoclonal islet cell reactive antibodies (mc-ICRA) in cellular enzyme-linked immunosorbent assay (CELISA). J. Immunol. Methods. 140:1991;101.
35. Sedgwick J.D., Czerkinsky C. Detection of cell-surface molecules, secreted products of single cells and cellular proliferation by enzyme immunoassay. J. Immunol. Methods. 150:1992;159.
36. Sharon M., Klausner R.D., Cullen B.R., Chizzonite R., Leonard W.J. Novel interleukin-2 receptor subunit detected by cross-linking under high affinity conditions. Science. 234:1986;859.
37. Smith K.A. Interleukin 2. Annu. Rev. Immunol. 2:1980;319.
38. Smith D.D., Cohick C.B., Lindsley H.B. Optimization of cellular ELISA for assay of surface antigens on human synoviocytes. Biotechniques. 22:1997;952.
39. Sun Q.H., Sun Y.X., Wang J.X. Analysis of epitopes using a recombinant CD25 fragment (residues 3-104) as antigen. Schlossman S.F., Boumsell L., Gilks W., Harlan J.M., Kishimoto T., Morimoto C., Ritz J., Shaw S., Silverstein R., Springer T., Tedder T.F., Todd R.F. Leucocyte Typing V: White Cell Differentiation Antigens. 1995;1907 Oxford Univ. Press, New York.
40. Takeshita T., Asao H., Ohtani K., Ishii N., Kumaki S., Tanaka N., Munakata H., Nakamura M., Sugamura K. Cloning of the γ-chain of the human IL-2 receptor. Science. 257:1992;379.
41. Taniguchi T., Minami Y. The IL-2/IL-2 receptor system: a current overview. Cell. 73:1993;5.
42. Tsudo M., Kitamura F., Miyasaka M. Characterization of the interleukin 2 receptor beta chain using three distinct monoclonal antibodies. Proc. Natl. Acad. Sci. U. S. A. 86:1989;1982.
43. Uchiyama T., Nelson D.L., Fleisher T.A., Waldmann T.A. A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T-cells. J. Immunol. 126:1981;1398.
44. Uchiyama T., Hori T., Tsudo M., Wano Y., Umadome H., Tamori S., Yodoi J., Maeda M., Sawami H., Uchino H. Interleukin-2 receptor (Tac antigen) expressed on adult T cell leukemia cells. J. Clin. Invest. 76:1985;446.
45. Urlacher A., Falkenrodt A., Tongio M.M., Mayer S. HLA class I antigens on normal and leukemic cells (quantitative analysis). Tissue Antigens. 29:1987;237.
46. Vincenti F., Kirkman R., Light S., Bumgardner G., Pescovitz M., Halloran P., Neylan J., Wilkinson A., Ekberg H., Gaston R., Backman L., Burdick J. Interleukin 2-receptor blockade with dacilzumab to prevent acute rejection in renal transplantation. N. Eng. J. Med. 338:1998;161.
47. Volund A. Application of the four-parameter logistic model to bioassay: comparison with slope ratio and parallel line models. Biometrics. 34:1978;357.
48. Waldmann T.A. The IL-2/IL-2 receptor system: a target for rational immune intervention. Immunol. Today. 14:1993;264.
49. Waldmann T.A., O'Shea J. The use of antibodies against the IL-2 receptor in transplantation. Curr. Opin. Immunol. 10:1998;507.
50. Waldmann T.A., White J.D., Goldman C.K., Top L., Grant A., Bamford R., Roessler E., Horak I.D., Zaknoen S., Kasten-Sportès C., England R., Horak E., Mishra B., Dipre M., Hale P., Fleisher T.A., Junghans R.P., Jaffe E.S., Nelson D.L. The interleukin-2 receptor: a target for monoclonal antibody treatment of human T-cell lymphotrophic virus I-induced adult T-cell leukemia. Blood. 82:1993;1701.
51. Walker K.W., Llull R., Balkian G.K., Ko H.S., Flores K.M., Ramsamooj R., Black K.S., Hewitt C.W., Martin D.C. A rapid and sensitive cellular enzyme-linked immunoabsorbent assay (CELISA) for the detection and quantitation of antibodies against cell surface determinants: I. A comparison of cell fixation and storage techniques. J. Immunol. Methods. 154:1992;121.